
Nucleate Podcast From science to startup: real talk on biotech founding paths | Hilary Schulz and Dr. Willliam Heath, Persephoni BioPartners
17 snips
Jun 27, 2025 Hilary Schulz, Co-founder and CEO of Persephoni BioPartners, and Dr. William Heath, Chief Scientific Officer, share their journeys from healthcare to biotech entrepreneurship. They discuss how co-founder dynamics can overshadow technology in startup success. The duo reveals critical insights on IP strategies, patient-centered approaches, and the importance of resilience in entrepreneurship. With real-world advice for navigating the biotech landscape, they emphasize the value of collaboration and a strong team to overcome challenges and drive lasting innovation.
AI Snips
Chapters
Transcript
Episode notes
Secure Proof and Licensing Right
- Ensure sufficient proof of concept before exiting technology from academia.
- Negotiate licensing with experienced advisors to avoid restrictive terms that harm future growth.
Build Strong IP Strategy
- Entrepreneurs must involve their inventors in licensing negotiations to ensure smooth patent ownership and control.
- Develop a broad patent strategy beyond just initial filings, including global protection and freedom to operate analyses.
Route of Delivery Matters
- Route of delivery often limits clinical viability, despite excellent preclinical results.
- Considering human factors and scalability early prevents failures in translation to patient use.
